AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,575 Cr | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr |
What is the latest Total Liabilities ratio of AARTI DRUGS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,575 Cr |
| Mar2024 | ₹2,432 Cr |
| Mar2023 | ₹2,421 Cr |
| Mar2022 | ₹2,208 Cr |
| Mar2021 | ₹1,766 Cr |
How is Total Liabilities of AARTI DRUGS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,575 Cr | 5.85 | |
| Mar2024 | ₹2,432 Cr | 0.45 | |
| Mar2023 | ₹2,421 Cr | 9.67 | |
| Mar2022 | ₹2,208 Cr | 25.02 | |
| Mar2021 | ₹1,766 Cr | - | |
Compare Total Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,380.4 Cr | -0.7% | -2.2% | -22.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.7% |
-2.2% |
-22.4% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses